Boost Run Inc. Details Hyper-Growth & $1.4B+ Contracted Revenue in New Investor Presentation
BRUN has more than doubled off its 52-week low of $10.01 on elevated volume (4.4× avg).
Summary
Boost Run Inc. released an investor presentation showcasing its rapid growth, including a $1.415 billion contracted revenue backlog and a positive financial outlook, aimed at attracting and informing investors.
Key Events · Financing and Capital Events · BRUN
-
Investor Presentation Released
Boost Run Inc. filed an investor presentation (Exhibit 99.1) detailing its financial and operational performance, including annual recurring revenue, contracted revenue backlog, and other key metrics.
-
Significant Contracted Revenue Backlog
The company reported a contracted revenue backlog of approximately $1.415 billion as of June 1, 2026, with the presentation stating it is on track to triple again by year-end 2026.
-
Hyper-Growth & Financial Outlook
The presentation emphasizes 'hyper-growth' with annual recurring revenue (ARR) tripling year-to-date and a projected 15-20%+ free cash flow margin for FY 2026E.
-
Strategic Partnerships & Footprint
Highlights preferred NVIDIA Cloud Partner status, NVIDIA Exemplar Cloud Status, and a scaled national platform with 8 data center sites, indicating strong industry positioning.
Analysis · BRUN · Technology
This 8-K furnishes a comprehensive investor presentation detailing Boost Run Inc.'s financial and operational performance. It highlights a significant contracted revenue backlog of approximately $1.415 billion as of June 1, 2026, and projects continued hyper-growth. This presentation reinforces the company's strong commercial momentum and capital discipline following its recent Nasdaq listing and SPAC merger, providing investors with a detailed outlook on its future revenue streams and operational strategy.
At the time of this filing, BRUN was trading at $38.01 on NASDAQ in the Technology sector. The 52-week trading range was $10.01 to $40.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.